Rucay P - Search Results

1

The Paul Brousse liver transplant series 1989 to 1992: new trends in the last four years.

Bismuth H, Samuel D, Castaing D, Adam R, Chiche L, Johann M, Azoulay D, Farges O, Feray C, Rucay P, et al. Bismuth H, et al. Among authors: rucay p. Clin Transpl. 1992:161-6. Clin Transpl. 1992. PMID: 1339127

2

FK 506 rescue therapy for refractory acute rejection in five liver recipients.

Rucay P, Samuel D, Gillet D, Bismuth H. Rucay P, et al. Transplant Proc. 1991 Dec;23(6):3000-1. Transplant Proc. 1991. PMID: 1721340 No abstract available.

3

FK 506 as treatment of late acute rejection in liver transplant patients.

Rucay P, Samuel D, Farges O, Reynes M, Bismuth H. Rucay P, et al. Transplant Proc. 1995 Feb;27(1):1105-6. Transplant Proc. 1995. PMID: 7533354 Clinical Trial. No abstract available.

4

Serum uric acid and liver transplantation.

Taillandier J, Alemanni M, Lioté F, Rucay P, Samuel D, Bismuth H. Taillandier J, et al. Among authors: rucay p. Transplant Proc. 1995 Jun;27(3):2189-90. Transplant Proc. 1995. PMID: 7792928 No abstract available.

5

Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantation.

Fries D, Rucay P, Samuel D, Hiesse C, Meduri G, Callard P, Fredj G, Bismuth H. Fries D, et al. Among authors: rucay p. Transplant Proc. 1991 Dec;23(6):3099-100. Transplant Proc. 1991. PMID: 1721370 No abstract available.

6

Study of the correlation between MEIA and ELISA methods for FK 506 determination in liver transplant recipients.

Rudant E, Bezie Y, Bonhomme-Faivre L, Manuel N, Rucay P, Fredj G, Bismuth H. Rudant E, et al. Among authors: rucay p. J Clin Pharm Ther. 1997 Apr;22(2):135-40. doi: 10.1111/j.1365-2710.1997.tb00007.x. J Clin Pharm Ther. 1997. PMID: 9373812

7

Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration.

Mattéi A, Rucay P, Samuel D, Feray C, Reynes M, Bismuth H. Mattéi A, et al. Among authors: rucay p. J Hepatol. 1995 May;22(5):597. doi: 10.1016/0168-8278(95)80458-7. J Hepatol. 1995. PMID: 7650341 No abstract available.

8

In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21.

Sadeg N, Pham-Huy C, Rucay P, Righenzi S, Halle-Pannenko O, Claude JR, Bismuth H, Duc HT. Sadeg N, et al. Among authors: rucay p. Immunopharmacol Immunotoxicol. 1993 Mar-Jun;15(2-3):163-77. doi: 10.3109/08923979309025992. Immunopharmacol Immunotoxicol. 1993. PMID: 8349948

9

Comparative evaluation of in vitro and in vivo immunosuppressive potential of cyclosporin G with cyclosporin A and FK-506.

Saada V, Pham-Huy C, Voisin J, Righenzi S, Rucay P, Claude JR, Duc HT. Saada V, et al. Among authors: rucay p. Int J Immunopharmacol. 1996 Jan;18(1):79-87. doi: 10.1016/0192-0561(95)00108-5. Int J Immunopharmacol. 1996. PMID: 8732436

10

Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line.

Massicot F, Martin C, Dutertre-Catella H, Ellouk-Achard S, Pham-Huy C, Thevenin M, Rucay P, Warnet JM, Claude JR. Massicot F, et al. Among authors: rucay p. Arch Toxicol. 1997;71(8):529-31. doi: 10.1007/s002040050423. Arch Toxicol. 1997. PMID: 9248632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters